Research
Clinical Research Program
This is a list of clinical trials and research protocols underway that will help us study thryoid malignancies and other endocrine neoplasias. If you would like to participate in one of the trials, please call the Information Line toll-free at 1-800-392-1611 or askMDAnderson at 1-877-MDA-6789. For information on other clinical trials, please visit MD Anderson's Clinical Trials Web site.
- Thyroid Cancer
- Pituitary Tumors
- Other Endocrine Neoplasias including solid tumors
- Other MD Anderson Clinical Trials relevant to Endocrine Neoplasia patients
Thyroid Cancer
A Phase II trial using RAD001 for patients with radioiodine refractory thyroid cancer.
Protocol 2010-0049
The goal of this clinical research study is to learn if RAD001 can help to control locally-advanced or metastatic thyroid cancer.
A Pharmacodynamic study of vemurafenib in the neoadjuvant setting in patients with locally advanced thyroid cancer.
Protocol 2012-0471
The goal of this clinical research study is to learn about how vemurafenib may affect certain biomarkers in patients with papillary thyroid cancer.
Vandetanib in Medullary Thyroid Cancer
Protocol 2011-1097
The goal of this clinical research study is to compare how effective 2 different doses of vandetanib may be in helping to control medullary thyroid cancer
Pituitary Tumors
ACROSTUDY - A Multicenter, Post Marketing Surveillance Study of Somavert Therapy in Patients with Acromegaly in the US and Europe
Protocol 2005-0222
The goal of this clinical research study is to look at the safety and effectiveness of long-term pegvisomant treatment for acromegaly
Other Endocrine Neoplasias, Including Solid Tumors
There are no clinical trials currently open for patients at the moment.
Other MD Anderson Clinical Trials Relevant to Endocrine Neoplasia Patients
A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates.
Protocol 2009-0595
The goal of this clinical research study is to learn if denosumab can help to control hypercalcemia in patients with cancer.
Last Updated: February 13, 2013
Download a PDF copy of the Department of Endocrine Neoplasia & HD's clinical trials flyer
The Rolanette and Berdon Lawrence Bone Disease Program of Texas
The Rolanette and Berdon Lawrence Bone Disease Program of Texas utilizes the high quality research and clinical programs of MD Anderson Cancer Center and Baylor College of Medicine to improve early and more accurate diagnosis, treatment and prevention of bone diseases such as osteoporosis and bone metastases afflicting the people of Texas.
Related Care Centers
Related Diseases
- Adrenal disease
- Endocrine Tumor - Childhood
- Hyperparathyroidism (see Parathyroid disease)
- Multiple Endocrine Neoplasia (MEN)
- Pancreatic cancer
- Parathyroid disease
- Pheochromocytoma (see Adrenal disease)
- Pituitary tumors
- Thyroid cancer
- von Hippel Lindau disease